Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre

Table 2

Micromorphometric features of SLN positive patients.

Micromorphometric features	𝑁 (%)
Size of metastasis
≤1 mm	15 (31.3)
>1 mm	24 (50.0)
Unknown	9 (18.7)
Intranodal location
Subcapsular	16 (33.3)
Parenchymal	9 (18.7)
Both	15 (31.3)
Extensive	6 (12.5)
Unknown	2 (4.2)
Number of metastatic foci
1	15 (35.7)
2–5	16 (38.1)
>5	11 (26.2)
Unknown	6 (12.5)
Extranodal invasion
Presence	9 (19.1)
Lymphatic invasion
Presence	10 (21.3)
CLND
Positive	13 (29.5)